Montag, 11. Dezember 2017


  • Pressemitteilung BoxID 49246

aap: CE-approval for new orthopaedic bone cement Hi-Fatigue® G with antibiotics

Berlin, (lifePR) - aap bio implants group, the medical biomaterials division of aap Implantate AG has received CE approval for the new orthopaedic bone cement Hi-Fatigue® G (containing the antibiotic Gentamycin). For the product family Hi-Fatigue® an exclusive distribution agreement was signed with Zimmer. The product will be launched in European markets by Zimmer, the global leader in reconstructive orthopaedic implants within the coming months.

aap Implantate AG is a medical technology company quoted in the prime standard of the Frankfurt Stock Exchange.
Diese Pressemitteilung posten:
Disclaimer